Trials / Withdrawn
WithdrawnNCT02238730
Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy
Comparative Efficacy and Cognitive Side-Effects of Ultrabrief Right Unilateral Electroconvulsive Therapy and Brief Pulse Bitemporal Electroconvulsive Therapy
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Kaiser Permanente · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the equivalent efficacy of ultrabrief pulsewidth right unilateral electroconvulsive therapy versus bitemporal brief pulse electroconvulsive therapy in the treatment of depression and to evaluate the cognitive effects of ultrabrief right unilateral electroconvulsive therapy versus bitemporal brief pulse electroconvulsive therapy.
Detailed description
Patients will be randomized to either bitemporal brief pulse electroconvulsive therapy ( 0.5 ms pulse width) or right unilateral ultrabrief pulse electroconvulsive therapy for the first six treatments. If further treatment is necessary, electrode placement will be chosen by the treating psychiatrist. All electroconvulsive therapy treatments will be performed with a Thymatron System IV instrument. (Somatics, LLC, Lake Bluff, Illinois, USA) Pre- electroconvulsive therapy testing will occur within one week of beginning treatment. Post-electroconvulsive therapy testing will occur within 48 hours of the 6th treatment.
Conditions
- Depression
- Depressive Disorder
- Treatment Resistant Depressive Disorder
- Bipolar Disorder
- Major Depressive Disorder
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ultrabrief Right Unilateral | The first six electroconvulsive therapy sessions using ultrabrief (0.25 ms) right unilateral electroconvulsive therapy |
| DEVICE | Brief Pulse Bitemporal | The first six electroconvulsive therapy sessions using brief pulse (0.5 ms) bitemporal electroconvulsive therapy |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2017-02-15
- Completion
- 2017-02-15
- First posted
- 2014-09-12
- Last updated
- 2017-02-17
Source: ClinicalTrials.gov record NCT02238730. Inclusion in this directory is not an endorsement.